How Parkinson’s Disease Affects Your Ability to Enjoy Pleasurable Scents

Research indicates that individuals with Parkinson’s disease often struggle to enjoy pleasant aromas, such as that of lemons. This intriguing finding suggests that “the world smells different” for those affected, presenting a potential opportunity for healthcare professionals to diagnose Parkinson’s disease using a cost-effective and non-invasive method, which traditionally requires several years and extensive evaluations.

The inability to detect scents is a primary symptom of Parkinson’s disease, affecting 75-90% of patients and frequently manifesting years or even decades prior to the characteristic tremors. Although numerous efforts have aimed to utilize olfactory loss as a diagnostic criterion, challenges arise since this sensory decline also occurs with normal aging.

Recently, Professor Noam Sobel and his team at the Weizmann Institute of Science in Rehovot, Israel, adopted a novel method of examining odor perception.

The study involved 94 participants, primarily aged 50 to 70. Among them, 33 were diagnosed with Parkinson’s disease, another 33 reported no known medical issues, while 28 were affected by anosmia not related to Parkinson’s. Standardized tests and surveys were employed to evaluate the participants’ ability to recognize and identify odors.

A unique feature of the study was the assessment of so-called olfactory fingerprints. Participants rated the intensity and pleasantness of scents from three bottles: one with a high concentration of lemon-scented citral, another containing a mix of compounds that emitted a feces-like odor, and a third bottle that was empty.

All tests observed periods of reduced olfactory ability, but only the olfactory perceptual fingerprint successfully differentiated between those with anosmia and individuals with Parkinson’s disease, achieving an impressive 88 percent accuracy. This accuracy rose to 94% when participants were matched by age and gender.

Interestingly, individuals with Parkinson’s disease reported perceiving citrus scents as equally strong compared to a healthy group, though both scent-related issues considered had lower comfort ratings than the healthy participants. Notably, those with Parkinson’s sniffed nearly 2 percent longer in response to unpleasant odors than lemon scents, while the other groups exhibited a decline in sniffing duration by 11 to 12 percent.

Sobel and his colleagues hypothesize that while the olfactory system remains functional in people with Parkinson’s disease, their brains interpret these signals differently, resulting in reduced enjoyment of pleasant scents and an involuntary sniffing response that is disconnected from the aroma’s pleasantness.

This phenomenon likely relates to alterations in brain regions like the anterior olfactory nucleus, which diminishes when odor signals are lost and is believed to be one of the initial sites of brain pathology in Parkinson’s disease.

Distinguishing between aging-related anosmia and that caused by Parkinson’s is immensely valuable. Michał Pieniak from the Smell and Taste Clinic at the Technical University of Dresden, Germany, highlights that around one in ten individuals seeking help for lost smell may, in fact, develop Parkinson’s disease. “If we can refine the identification of their personal risk, it would be a major breakthrough.”

Charles Greer, a professor at Yale University School of Medicine, asserts that this innovative method shows remarkable potential but emphasizes the necessity for further testing with a larger population. Given that olfactory loss can precede other Parkinson’s symptoms by years, it may take considerable time to fully evaluate this approach.